BioKinetic are proud to have partnered with LifeScan Scotland Ltd on a recent digital diabetes study that has been published on JMIR Publications
The objective of the study was to assess changes in glycemic control and overall patient experiences when using LifeScan’s wireless OneTouch Verio Flex Blood Glucose Meter.
In total, 137 adults with Type 1 or 2 diabetes mellitus were assigned either the glucose meter alone or glucose meter plus the mobile app for 24 weeks. The group using both meter and app were scheduled to receive diabetes related text messages from their healthcare professional every 2 weeks.
The results showed that the use of the One Touch Verio Flex glucose meter alone or in combination with the One Touch Reveal diabetes app was associated with significant improvements in glycemic control after 12 and 24 weeks. Improvements using the app were greatest in Type 2 participants and those who received the highest number of text messages. This study suggests that real-time availability of patient data and the ability to send personalized diabetes-related text messages can help to improve glycemic control in patients.
Please click here to read more.